The drug development sector in the United States is experiencing a significant surge in requirement for Tirzepatide APIs. This powerful medication, used to treat type 2 diabetes, has captured considerable attention from both patients and healthcare professionals. As a result, numerous manufacturers have emerged as suppliers of Tirzepatide APIs in t